
|Articles|April 16, 2007
Latebreakers: Combo diabetes drug gets FDA nod
The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Trump Administration Looking to Bypass PBMs Through Online DTC Pharmacy
2
ACIP Vote Eliminates Universal Recommendation for Newborn Hepatitis B Vaccine
3
Pharmacists Remain Health Care Focal Point as Vaccine Recommendations Change
4
Pharmacists Now Authorized to Independently Prescribe Buprenorphine
5



































































































































